Relationship of oxidative stress in hepatitis B infection activity with HBV DNA and fibrosis

Annals of Laboratory Medicine

Volumn 32, Issue 2, 2012, Pages 113-118

  Duygu, Fazilet ^a,c   Karsen, Hasan ^b   Aksoy, Nurten ^b   Taskin, Abdullah ^b  

^a Tokat State Hospital   (Turkey)

^b HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c NONE   (Turkey)

Author keywords

Catalase; Fibrosis; HBV DNA; Hepatitis b; Oxidative stress; Sulfhydryl

Indexed keywords

EID: 84859183283     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2012.32.2.113     Document Type: Article

References (35)

1. Koziel MJ and Siddiqui A. Hepatitis B virus and hepatitis Delta virus. In: Mandeli GL, Douglas RG, et al. eds. Principles and practice of infectious diseases. 6th ed. Philadelphia: Churchill Livingstone, 2005:1864-90.
2. Koff RS. Viral hepatitis. In: Schiff L and Schiff ER, eds. Diseases of the liver. 7th ed. Philadelphia: JB Uppincott Company, 1993:492-577.
3. Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, et al. Oxidative stress inthe absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 2001;61: 4365-70. (Pubitemid 32685760)
4. Dikici I, Mehmetoǧlu I, Dikicl N, Bitirgen M, Kurban S. Investigation ofoxidative stress and some antioxidants in patients with acute and chronic viral hepatitis B and the effect of interferon-α treatment. Clin Biochem 2005;38:1141-4. (Pubitemid 41799605)
5. Anna S. F. Lok L and Brian J. McMahon. AASLD Practice Guidelines Chronic Hepatitis B: Update 2009.
6. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application ofnumerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5. (Pubitemid 12218164)
7. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112-229.
8. Góth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 1991;196:143-51.
9. Ellman GLTissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.
10. Hu ML, Louie S, Cross CE, Motchnik P, Halliwell B. Antioxidant protection against hyochlorous acid in human plasma. J Lab Clin Med 1993; 121:257-62. (Pubitemid 23073132)
11. Conti M, Morand PC, Levillain P, Lemonnier A. Improved fluorometric determination ofmalondialdehyde. Clin Chem 1991;37:1273-5.
12. Sunderman FW Jr and Nomoto S. Measurement ofhuman serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chem 1970; 16:903-10.
13. Pawlotsky JM. The concept of hepatitis B virus mutant escape. J Clin Virol 2005;34(S1):125-9.
14. Curry MP and Chopra S. Acute viral hepatitis. In: Mandell GL, Bennett JE, et al. eds. Principles and practice of infectious diseases. 6th ed. Philadelphia: Churchill Livingstone, 2005:1426-41.
15. Abdollahi M, Bahreini-Moghadam A, Emami B, Fooladian F, Zafariet K. Increasing intracellular cAMP and cGMP inhibits cadmium-induced oxidative stress in rat submandibular saliva. Comp Biochem Physol C Toxicol Pharmacol 2003;135:331-6. (Pubitemid 36962946)
16. Abdollahi M, Ranjbar A, Shadnia S, Nikfar S, Rezaie A. Pesticides and oxidative stress: a review. Med Sci Monit 2004;10:141-7.
17. Yeum KJ, Russell RM, Krinsky NI, Adlini G. Biomarkers ofantioxidant capacity in the hydrophilic and lipophilic compartments of human plasma. Arch of Biochem Biophys. 2004;430:97-103. (Pubitemid 39119784)
18. Yagi K. Lipid peroxidase and related radicals in clinical medicine. In: Armstrong D, ed. Free radicals in diagnostic medicine. New York: Plenum Press, 1994:17-27.
19. Erel O. A new automoted colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103-11.
20. Halliwell B. Drug antioxidant effects. Drugs 1991;42:569-605.
21. Jain SK, Pemberton PW, Smith A, McMahon RF, Burrows PC, Aboutwerat A, et al. Oxidative stress inchronic hepatitis C: not just a feature of late stage disease. J Hepatol 2002;36:805-11. (Pubitemid 35177411)
22. Aksoy N, Vural H, Sabuncu T, Aksoy S. Effects ofmelatonin on oxidativeantioxidative status of tissues in streptozotocin-induced diabetic rats. Cell biochem Funct 2003;21:121-5. (Pubitemid 36597178)
23. Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, et al. Oxygene radicals and human disease. Ann Intern Med 1987;107:526-45.
24. Vural H, Sabuncu T, Arslan SO, Aksoy N. Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats. J Pineal Res 2001;31:193-8. (Pubitemid 32905227)
25. Swierczynski J, Kochan Z, Mayer D. Dietary α-tocopherol prevents dehydropiandrosterone-induced lipid peroxidation in rat liver microsomes and mitochondria. Toxicol Lett 1997;91:129-36. (Pubitemid 27214564)
26. Gantt KR, Goldman TL, McCormick ML, Miller MA, Jeronimo SM, Nascimento ET, et al. Oxidative responses ofhuman and murine macrophages during phagocytosis of Leishmania chagasi. J Immunol 2001;167:893-901. (Pubitemid 32660845)
27. Murray HW and Teitelbaum RF. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J Infect Dis 1992;165:513-7.
28. Cemek M, Dede S, Bayiroglu F, Caksen H, Cemek F, Mert N. Oxidant and non-enzymatic antioxidant status in measles. J Trop Pediatr 2007; 53:83-6. (Pubitemid 46567310)
29. Draganov D, Teiber J, Watson C. Bisqaier C, Nemzek J, Remick D, et al. PON1 and oxidative stress in human sepsis and an animal model of sepsis. Adv Exp Med Biol 2010;660:89-97.
30. Bayraktar N, Kilic S, Bayraktar Mr, Aksoy N.Lipid peroxidation and antioxidant enzyme activities in cancerous bladder tissue and their relation with bacterial infection: a controlled clinical study. J Clin Lab Anal 2010; 24:25-30.
31. Lin CC, Liu WH, Wang ZH, Yin MC. Vitamins Bstatus and antioxidative defense in patients with chronic hepatitis B or hepatitis C virus infection. Eur J Nutr 2011;50499-506.
32. Kageyama F, Kobayashi Y, Kawasaki T, Toyokuni S, Uchida K, Nakamura H. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C. Am J Gastroenterol 2000;95:1041-50. (Pubitemid 30196744)
33. Mahmood S, Kawanaka M, Kamei A, Izumi A, Nakata K, Niiyama G, et al. Immunohistochemical evaluation ofoxidative stress markers in chronic hepatitis C. Antioxid Redox Signal 2004;6:19-24. (Pubitemid 38063973)
34. Demirdag K, Yilmaz S, Ozdarendeli A, Ozden M, Kalkan A, Kilic SS. Levels ofplasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B. Hepatogastroenterology 2003; 50:766-70. (Pubitemid 36613401)
35. Bolukbas C, Bolukbas FF, Horoz M, Asian M, Celik H, Erel O. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis 2005;5:95.